Stock Ratings | Wells Fargo raised its price target for CoreWeave (CRWV) to $155; while Guggenheim maintained its price target for Janux (JANX) at $58, still representing a potential upside of 309.17%.

Artiva Biotherapeutics, Inc.
Cullinan Therapeutics, Inc.
Nektar Therapeutics
AirJoule Technologies Corporation Class A
Janux Therapeutics, Inc.

Artiva Biotherapeutics, Inc.

ARTV

0.00

Cullinan Therapeutics, Inc.

CGEM

0.00

Nektar Therapeutics

NKTR

0.00

AirJoule Technologies Corporation Class A

AIRJ

0.00

Janux Therapeutics, Inc.

JANX

0.00

The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.

Risk warning:

Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.

Today's key assessments and concerns

HC Wainwright & Co.: Maintaining a "buy" rating on Artiva Biotherapeutics ( Artiva Biotherapeutics, Inc.(ARTV.US) ), while raising the price target from $15 to $35.

Wedbush: Maintaining Cullinan Therapeutics ( Cullinan Therapeutics, Inc.(CGEM.US) ) rating at "Outperform Market", while raising the price target from $36 to $37.

Piper Sandler: Maintaining Nektar Therapeutics' rating ( Nektar Therapeutics(NKTR.US) ) at "Overweight", while raising the price target from $105 to $192.

Seaport Global: Initial rating for AirJoule Technologies ( AirJoule Technologies Corporation Class A(AIRJ.US) ) stock at "Buy", with a target price of $7.

Guggenheim: Maintaining a "buy" rating on Janux Therapeutics ( Janux Therapeutics, Inc.(JANX.US) ), while lowering the price target from $68 to $58.

The symbol Classification Target price Current price Percentage of potential increase/decrease (Classification) Agency
Artiva Biotherapeutics, Inc.(ARTV.US) to lift $35.0 $10.89 221.4% HC Wainwright & Co.
Cullinan Therapeutics, Inc.(CGEM.US) to lift $37.0 $14.55 154.3% Wedbush
Nektar Therapeutics(NKTR.US) to lift $192.0 $81.89 134.46% Piper Sandler
Zevra Therapeutics, Inc.(ZVRA.US) to lift $25.0 $11.13 124.62% Guggenheim
Celsius Holdings, Inc.(CELH.US) to lift $70.0 $32.29 116.79% JP Morgan
AirJoule Technologies Corporation Class A(AIRJ.US) Initial classification $7.0 $3.55 97.18% Seaport Global
Janux Therapeutics, Inc.(JANX.US) cut $58.0 $14,175 309.17% Guggenheim
enGene Holdings(ENGN.US) cut $6.0 $1.5 300.0% HC Wainwright & Co.
Iovance Biotherapeutics Inc(IOVA.US) cut $14.0 $3.62 286.74% Chardan Capital
Verastem, Inc.(VSTM.US) cut $18.0 $4.89 268.1% BTIG

comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)

Lifting

UBS: Maintaining a "buy" rating on AppLovin ( AppLovin(APP.US) ), while raising the price target from $716 to $750.

Barclays: Maintaining Arm Holdings(ARM.US) Holdings' rating at "overweight", while raising the price target from $200 to $250.

Mizuho: Maintaining a "neutral" rating on CoreWeave ( CoreWeave(CRWV.US) ), while raising its price target from $105 to $110.

Wells Fargo: Maintaining CoreWeave's ( CoreWeave(CRWV.US) ) rating at "Overweight", while raising the price target from $135 to $155.

Rosenblatt: Maintaining a "buy" rating on Datadog ( Datadog(DDOG.US) ) stock, while raising the price target from $178 to $220.

Macquarie: Maintaining Datadog's ( Datadog(DDOG.US) ) rating at "Outperforming the Market," while raising the price target from $200 to $230.

Tigress Financial: Maintaining a "buy" rating on Qualcomm ( QUALCOMM Incorporated(QCOM.US) ) stock, while raising the price target from $270 to $280.

TD Cowen: Maintaining a "buy" rating on Rocket Rocket Lab(RKLB.US) ) stock, while raising the price target from $90 to $120.

Citizens: Maintaining its "outperform" rating for Rocket Lab Rocket Lab(RKLB.US) , while raising its price target from $85 to $95.

First Coverage

Seaport Global: Initial rating for AirJoule Technologies ( AirJoule Technologies Corporation Class A(AIRJ.US) ) stock at "Buy", with a target price of $7.

HSBC: Applied Materials ( Applied Materials, Inc.(AMAT.US) stock has a preliminary "buy" rating, with a target price of $517.

JP Morgan: Initial rating for CEVA ( CEVA, Inc.(CEVA.US) ) stock at "neutral", with a price target of $30.

reduction

JP Morgan: Maintaining Coinbase Global Coinbase(COIN.US) ) rating at "overweight", while lowering the price target from $290 to $283.

Wells Fargo: Maintaining McDonald's McDonald's Corporation(MCD.US) rating at "overweight," while lowering the target price from $355 to $320.

Wells Fargo: Downgraded Nike ( NIKE, Inc. Class B(NKE.US) ) stock to "market-weighted", with a price target cut from $55 to $45.

Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.